Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

5.61
Delayed Data
As of Feb 17
 -0.15 / -2.60%
Today’s Change
4.39
Today|||52-Week Range
9.29
-2.77%
Year-to-Date
5 Ways Allergan Can Keep Up Momentum
Feb 15 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close5.76
Today’s open5.75
Day’s range5.59 - 5.78
Volume2,015,510
Average volume (3 months)2,850,735
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+5.44%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book15.83

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.50+2.10%
SGYPSynergy Pharmaceutic...+0.01+0.17%
IPXLImpax Laboratories I...0.000.00%
LOXOLoxo Oncology Inc+0.36+0.87%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts


Search for Jobs